Biotech Values

[DewDiligence]

With the benefit of hindsight, I think BRL’s receptiveness to a near-term buyout was evident on the company’s 8-May-2008 CC. Downey was badgered by analysts for the botched quarterly results; instead of retaliating abrasively as he normally does, Downey sounded like Bobby McFerrin singing Don’t Worry Be Happy.


Let’s talk biotech!
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”